Skip to content

Clinical trials

Phase 3 Agammaglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Agammaglobulinemia Phase: Phase 3 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20051
20061
20121
20181
20191
20201
20211
20221
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring4
Kedrion S.p.A.3
Grifols Therapeutics LLC2
Octapharma2
Bio Products Laboratory1
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes1
On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Agammaglobulinemia14
Common Variable Immunodeficiency5
Primary Immunodeficiency Diseases5
IgG Deficiency3
Leukemia, Lymphocytic, Chronic, B-Cell3
Immunologic Deficiency Syndromes2
Wiskott-Aldrich Syndrome2
Bacterial Infections1
Burkitt Lymphoma1
Hematologic Neoplasms1

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.